Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells

Neuroscience

Volumn 161, Issue 4, 2009, Pages 978-987

  Utreras, E ^a   Maccioni, R ^b   Gonzalez Billault C ^a  

^a Centre for Biochemical Engineering and Biotechnology   (Chile)

^b Faculty of Sciences   (Chile)

Author keywords

Alzheimer's disease; apoptosis; cleaved caspase 3; hippocampal neurons; neuro 2a cell line; Tet off

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CASPASE 3; CYCLIN DEPENDENT KINASE 5; DNA NUCLEOTIDYLEXOTRANSFERASE; ENZYME ACTIVATOR; PROTEIN P35; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; MOUSE; NERVE CELL; NERVE CELL CULTURE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; IN SITU NICK-END LABELING; MICE; MICROSCOPY, CONFOCAL; NEURONS; PEPTIDE FRAGMENTS; PHOSPHOTRANSFERASES; PROTEIN SYNTHESIS INHIBITORS; TETRACYCLINE; TRANSFECTION;

EID: 67349194039     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.04.002     Document Type: Article

References (38)

1. Ahlijanian M.K., Barrezueta N.X., Williams R.D., Jakowski A., Kowsz K.P., McCarthy S., Coskran T., Carlo A., Seymour P.A., Burkhardt J.E., Nelson R.B., and McNeish J.D. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. Proc Natl Acad Sci U S A 97 (2000) 2910-2915
2. Alvarez A., Munoz J.P., and Maccioni R.B. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp Cell Res 264 (2001) 266-274
3. Alvarez A., Toro R., Caceres A., and Maccioni R.B. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett 459 (1999) 421-426
4. Banker G.A., and Cowan W.M. Rat hippocampal neurons in dispersed cell culture. Brain Res 126 (1977) 397-342
5. Baron U., Freundlieb S., Gossen M., and Bujard H. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23 (1995) 3605-3606
6. Cheung Z.H., Gong K., and Ip N.Y. Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. J Neurosci 28 (2008) 4872-4877
7. Cruz J.C., and Tsai L.H. Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 10 (2004) 452-458
8. Dhariwala F.A., and Rajadhyaksha M.S. An unusual member of the cdk family: cdk5. Cell Mol Neurobiol 28 (2008) 351-369
9. Dhavan R., and Tsai L.H. A decade of CDK5. Nat Rev Mol Cell Biol 2 (2001) 749-759
10. Eilers A., Whitfield J., Babij C., Rubin L.L., and Ham J. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons. J Neurosci 18 (1998) 1713-1724
11. Evans K.C., Berger E.P., Cho C.G., Weisgraber K.H., and Lansbury Jr. P.T. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A 92 (1995) 763-767
12. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89 (1992) 5547-5551
13. Han P., Dou F., Li F., Zhang X., Zhang Y.W., Zheng H., Lipton S.A., Xu H., and Liao F.F. Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation. J Neurosci 25 (2005) 11542-11552
14. Hong M., Chen D.C., Klein P.S., and Lee V.M. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 272 (1997) 25326-25332
15. Kerokoski P., Suuronen T., Salminen A., Soininen H., and Pirttila T. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation. Biochem Biophys Res Commun 298 (2002) 693-698
16. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., and Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405 (2000) 360-364
17. Lew J., Huang Q.Q., Qi Z., Winkfein R.J., Aebersold R., Hunt T., and Wang J.H. A brain-specific activator of cyclin-dependent kinase 5. Nature 371 (1994) 423-426
18. Li B.S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., Kulkarni A.B., and Pant H.C. Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 278 (2003) 35702-35709
19. Li B.S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A.B., and Pant H.C. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21 (2002) 324-333
20. Liu T., Perry G., Chan H.W., Verdile G., Martins R.N., Smith M.A., and Atwood C.S. Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. J Neurochem 88 (2004) 554-563
21. Maccioni R.B., Otth C., Concha II M.J.P., and Munoz J.P. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 268 (2001) 1518-1527
22. Maloney M.T., Minamide L.S., Kinley A.W., Boyle J.A., and Bamburg J.R. Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J Neurosci 25 (2005) 11313-11321
23. Mandelkow E.M., Biernat J., Drewes G., Steiner B., Lichtenberg-Kraag B., Wille H., Gustke N., and Mandelkow E. Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann N Y Acad Sci 695 (1993) 209-216
24. Meuer K., Suppanz I.E., Lingor P., Planchamp V., Goricke B., Fichtner L., Braus G.H., Dietz G.P., Jakobs S., Bahr M., and Weishaupt J.H. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ 14 (2007) 651-661
25. Munoz J.P., Alvarez A., and Maccioni R.B. Increase in the expression of the neuronal cyclin-dependent protein kinase cdk-5 during differentiation of N2A neuroblastoma cells. Neuroreport 11 (2000) 2733-2738
26. Noble W., Olm V., Takata K., Casey E., Mary O., Meyerson J., Gaynor K., LaFrancois J., Wang L., Kondo T., Davies P., Burns M., Veeranna, Nixon R., Dickson D., Matsuoka Y., Ahlijanian M., Lau L.F., and Duff K. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38 (2003) 555-565
27. Pareek T.K., and Kulkarni A.B. Cdk5: a new player in pain signaling. Cell Cycle 5 (2006) 585-588
28. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
29. Patzke H., Maddineni U., Ayala R., Morabito M., Volker J., Dikkes P., Ahlijanian M.K., and Tsai L.H. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene. J Neurosci 23 (2003) 2769-2778
30. Porter A.G., and Jänicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6 (1999) 99-104
31. Schneider A., Biernat J., von Bergen M., Mandelkow E., and Mandelkow E.M. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38 (1999) 3549-3558
32. Selkoe D.J. Biochemistry of altered brain proteins in Alzheimer's disease. Annu Rev Neurosci 12 (1989) 463-490
33. Takahashi S., Ohshima T., Cho A., Sreenath T., Iadarola M.J., Pant H.C., Kim Y., Nairn A.C., Brady R.O., Greengard P., and Kulkarni A.B. Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci U S A 102 (2005) 1737-1742
34. Tsai L.H., Delalle I., Caviness Jr. V.S., Chae T., and Harlow E. p35 Is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371 (1994) 419-423
35. Tseng H.C., Zhou Y., Shen Y., and Tsai L.H. A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains. FEBS Lett 523 (2002) 58-62
36. Utreras E., Futatsugi A., Rudrabhatla P., Keller J., Iadarola M.J., Pant H.C., and Kulkarni A.B. Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem 284 (2009) 2275-2284
37. Weishaupt J.H., Neusch C., and Bahr M. Cyclin-dependent kinase 5 (CDK5) and neuronal cell death. Cell Tissue Res 312 (2003) 1-8
38. Zheng Y.L., Kesavapany S., Gravell M., Hamilton R.S., Schubert M., Amin N., Albers W., Grant P., and Pant H.C. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons. EMBO J 24 (2005) 209-220